ECSP056110A - Revestimiento anti-fúngico para uñas y método de uso - Google Patents

Revestimiento anti-fúngico para uñas y método de uso

Info

Publication number
ECSP056110A
ECSP056110A EC2005006110A ECSP056110A ECSP056110A EC SP056110 A ECSP056110 A EC SP056110A EC 2005006110 A EC2005006110 A EC 2005006110A EC SP056110 A ECSP056110 A EC SP056110A EC SP056110 A ECSP056110 A EC SP056110A
Authority
EC
Ecuador
Prior art keywords
fungicidal
composition
coat
amount
nails
Prior art date
Application number
EC2005006110A
Other languages
English (en)
Inventor
Stanley W Kepka
Y Joseph Mo
Hang-Yong Wang
Mingqi Lu
William R Pfister
Original Assignee
Nexmed Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nexmed Holdings Inc filed Critical Nexmed Holdings Inc
Publication of ECSP056110A publication Critical patent/ECSP056110A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/806—Drug, bio-affecting and body treating compositions involving IgM
    • Y10S424/807—Monoclonal
    • Y10S424/808—Human

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Se describe una composición de revestimiento anti-fúngico para uñas de doble acción y método de uso para mejorar ó prevenir la infección fúngica de las uñas, y onicomicosis, en particular. Se describen las modalidades de la composición en la forma de un tipo de un revestimiento y de un tipo de dos revestimientos adecuados para regímenes fungicidas diarios. Una composición de revestimiento anti-fúngico para uñas comprende una cantidad fungicida efectiva de agente anti-fúngico, una cantidad de un aumentador de permeación, substancialmente no volátil, que aumenta la permeación, una cantidad de un polímero hidrofílico que forma una película, y un vehículo volátil farmacéuticamente aceptable. La composición proporciona un revestimiento fungicida substancialmente soluble en agua al poner en contacto con una uña infectada ó susceptible a infección fungicida.
EC2005006110A 2003-03-21 2005-10-20 Revestimiento anti-fúngico para uñas y método de uso ECSP056110A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45668403P 2003-03-21 2003-03-21

Publications (1)

Publication Number Publication Date
ECSP056110A true ECSP056110A (es) 2006-03-01

Family

ID=33098141

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005006110A ECSP056110A (es) 2003-03-21 2005-10-20 Revestimiento anti-fúngico para uñas y método de uso

Country Status (28)

Country Link
US (3) US7462362B2 (es)
EP (2) EP2106805B1 (es)
JP (1) JP4540667B2 (es)
KR (1) KR101093990B1 (es)
CN (2) CN102973420A (es)
AT (2) ATE512672T1 (es)
AU (1) AU2004224326B2 (es)
BR (1) BRPI0408613A (es)
CA (1) CA2519705C (es)
CO (1) CO5640092A2 (es)
CY (1) CY1111773T1 (es)
DE (1) DE602004021253D1 (es)
DK (2) DK1635770T3 (es)
EC (1) ECSP056110A (es)
ES (1) ES2366273T3 (es)
HR (1) HRP20050918A2 (es)
IL (1) IL170963A (es)
IS (1) IS8078A (es)
MA (1) MA27760A1 (es)
MX (1) MXPA05010114A (es)
NO (1) NO335895B1 (es)
NZ (1) NZ542904A (es)
PL (1) PL2106805T3 (es)
RU (1) RU2358718C2 (es)
SG (1) SG152065A1 (es)
TN (1) TNSN05231A1 (es)
WO (1) WO2004084826A2 (es)
ZA (1) ZA200507972B (es)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050238672A1 (en) * 2004-04-27 2005-10-27 Nimni Marcel E Antifungal drug delivery
US20060275230A1 (en) 2004-12-10 2006-12-07 Frank Kochinke Compositions and methods for treating conditions of the nail unit
KR20070095921A (ko) 2004-12-10 2007-10-01 탈리마 테라퓨틱스 인코포레이티드 조갑 단위의 상태를 치료하기 위한 조성물 및 방법
EP1698336A1 (en) * 2005-03-01 2006-09-06 Ferrer Internacional, S.A. Antifungal compositions comprising Sertaconazole and either Hydrocortisone or an antibacterial agent
FR2892023B1 (fr) * 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
MX2008008413A (es) * 2006-01-02 2008-09-04 Tlt Medical Ltd Composicion farmaceutica para el tratamiento de las enfermedades de las uñas.
WO2007098591A2 (en) * 2006-03-02 2007-09-07 Nuvo Research Inc. Topical nail formulation
ES2421613T3 (es) 2006-03-08 2013-09-04 Nihon Nohyaku Co Ltd Composición farmacéutica externa
RU2415669C2 (ru) 2006-03-08 2011-04-10 Нихон Нохияку Ко., Лтд. Фармацевтическая композиция для наружного применения
MX2008011433A (es) 2006-03-08 2008-09-18 Nihon Nohyaku Co Ltd Composicion farmaceutica para uso externo.
JP5453093B2 (ja) 2007-09-05 2014-03-26 株式会社ポーラファルマ 抗真菌医薬組成物
KR20100075475A (ko) 2007-09-05 2010-07-02 가부시키가이샤 폴라 파마 의약 조성물
KR20100075476A (ko) 2007-09-05 2010-07-02 가부시키가이샤 폴라 파마 항진균 조성물
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
RU2526162C2 (ru) 2008-10-03 2014-08-20 Нексмед Холдингз, Инк. Стабилизированная композиция для лечения псориаза
RU2011120054A (ru) * 2008-10-21 2012-11-27 Новодермикс Интернэшнл Лимитед Композиции для лечения эпителиальной ткани
WO2010047288A1 (en) 2008-10-24 2010-04-29 Semiconductor Energy Laboratory Co., Ltd. Method for manufacturing semiconductordevice
EP2370406A4 (en) * 2008-12-04 2014-02-19 Chongxi Yu COMPOSITIONS WITH HIGH PENETRATION AND ITS APPLICATIONS
US20100291182A1 (en) * 2009-01-21 2010-11-18 Arsenal Medical, Inc. Drug-Loaded Fibers
WO2010086725A1 (en) * 2009-01-30 2010-08-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Compositions for nail and skin treatment
WO2010086727A1 (en) * 2009-01-30 2010-08-05 Galderma Pharma Sa Stable compositions for nail onychomycosis treatment
EP2416758B8 (en) 2009-04-09 2017-10-18 Pola Pharma Inc. Antimycotic pharmaceutical composition
WO2010117089A2 (en) 2009-04-09 2010-10-14 Pola Pharma Inc. Antimycotic pharmaceutical composition
WO2011014850A2 (en) 2009-07-31 2011-02-03 Nuvo Research Inc. Topical eutectic-based formulations
US20110202016A1 (en) * 2009-08-24 2011-08-18 Arsenal Medical, Inc. Systems and methods relating to polymer foams
US9044580B2 (en) 2009-08-24 2015-06-02 Arsenal Medical, Inc. In-situ forming foams with outer layer
US9173817B2 (en) 2009-08-24 2015-11-03 Arsenal Medical, Inc. In situ forming hemostatic foam implants
US10420862B2 (en) 2009-08-24 2019-09-24 Aresenal AAA, LLC. In-situ forming foams for treatment of aneurysms
US8952044B2 (en) 2009-08-25 2015-02-10 Pola Pharma Inc. Antimycotic pharmaceutical composition
JPWO2011052224A1 (ja) * 2009-11-02 2013-03-14 株式会社福元技研 皮膚美容用混練組成物およびその製造方法、皮膚美容用混練組成物の使用方法
AU2010336441B2 (en) * 2009-12-23 2015-02-05 Nuvo Research Inc. Highly permeating terbinafine formulation for treating onychomycosis
CN102858364A (zh) * 2010-05-04 2013-01-02 尼克美控股公司 治疗肽组合物和方法
SG186299A1 (en) 2010-05-04 2013-01-30 Nexmed Holdings Inc Compositions of small molecule therapeutics
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
RU2432158C1 (ru) * 2010-07-28 2011-10-27 Закрытое акционерное общество "Институт прикладной нанотехнологии" Профилактический бактерицидный лак для обработки ногтей
SG10201803321TA (en) * 2010-12-02 2018-06-28 Ferring Int Center Sa Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate
US9034240B2 (en) 2011-01-31 2015-05-19 Arsenal Medical, Inc. Electrospinning process for fiber manufacture
US9194058B2 (en) 2011-01-31 2015-11-24 Arsenal Medical, Inc. Electrospinning process for manufacture of multi-layered structures
US8968626B2 (en) 2011-01-31 2015-03-03 Arsenal Medical, Inc. Electrospinning process for manufacture of multi-layered structures
CN103459394B (zh) * 2011-04-08 2016-04-27 辉瑞大药厂 结晶和非结晶形式的托法替尼，以及包含托法替尼和渗透增强剂的药物组合物
JP6077527B2 (ja) * 2011-05-11 2017-02-08 ヴェローチェ・バイオファーマ・エルエルシー 皮膚および爪の治療のための抗真菌組成物
CA2745320A1 (en) 2011-07-06 2013-01-06 Duoject Medical Systems Inc. Reconstitution device
US8993831B2 (en) 2011-11-01 2015-03-31 Arsenal Medical, Inc. Foam and delivery system for treatment of postpartum hemorrhage
ES2734357T3 (es) * 2012-02-17 2019-12-05 Veloce Biopharma Llc Composiciones antifúngicas para uso en el tratamiento de enfermedades de la piel
CA2775393C (en) * 2012-05-02 2014-04-29 Samy Saad Topical non-aqueous pharmaceutical formulations
AR091934A1 (es) 2012-07-30 2015-03-11 Meiji Seika Pharma Co Ltd Parche para antidermatofitosis
TW201410239A (zh) * 2012-07-30 2014-03-16 Meiji Seika Pharma Co Ltd 抗白癬菌症外用液劑
US8900625B2 (en) * 2012-12-15 2014-12-02 Nexmed Holdings, Inc. Antimicrobial compounds and methods of use
US8697753B1 (en) * 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
US9498612B2 (en) 2013-03-14 2016-11-22 Hallux, Inc. Method of treating infections, diseases or disorders of nail unit
WO2014159930A1 (en) * 2013-03-14 2014-10-02 Alc Therapeutics, Llc Antifungal compositions for the treatment of secondary skin and nail infections
GB201317005D0 (en) * 2013-09-25 2013-11-06 Blueberry Therapeutics Ltd Composition and methods of treatment
US9662394B2 (en) 2013-10-03 2017-05-30 Dow Pharmaceutical Sciences, Inc. Stabilized efinaconazole compositions
CN105848719A (zh) 2013-11-22 2016-08-10 道尔医药科学公司 抗感染的方法、组合物和装置
EP2952208A1 (en) * 2014-06-04 2015-12-09 Universidade de Santiago de Compostela Hydroalcoholic system for nail treatment
KR102137861B1 (ko) 2014-08-13 2020-07-24 메이지 세이카 파루마 가부시키가이샤 결정성 항백선균약 및 그 제조 방법
WO2016118424A1 (en) 2015-01-20 2016-07-28 Veloce Biopharma Llc Novel iodophor composition and methods of use
JP6591100B1 (ja) * 2019-01-25 2019-10-16 ロート製薬株式会社 爪及び爪周り用医薬組成物
CN112791048B (zh) * 2020-12-31 2023-01-17 海南海神同洲制药有限公司 一种硝酸舍他康唑栓及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE10272T1 (de) 1979-08-22 1984-11-15 Sandoz Ag Propenylamine, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und ihre verwendung als arzneimittel.
DE3045914A1 (de) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
US4406509A (en) * 1981-11-25 1983-09-27 E. I. Du Pont De Nemours & Co. Jack and plug electrical assembly
DE3544983A1 (de) * 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
US4861764A (en) 1986-11-17 1989-08-29 Macro Chem. Corp. Percutaneous absorption enhancers, compositions containing same and method of use
FR2613227B1 (fr) * 1987-04-01 1990-12-28 Oreal Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
US4980378A (en) 1988-06-01 1990-12-25 Odontex, Inc. Biodegradable absorption enhancers
US5082866A (en) * 1988-06-01 1992-01-21 Odontex, Inc. Biodegradable absorption enhancers
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
EP0746294B1 (en) * 1993-10-07 2004-12-22 Odontex, Inc. Absorption enhancers for topical pharmaceutical formulations
US6019988A (en) * 1996-11-18 2000-02-01 Bristol-Myers Squibb Company Methods and compositions for enhancing skin permeation of drugs using permeation enhancers, when drugs and/or permeation enhancers are unstable in combination during long-term storage
US6046244A (en) * 1997-11-05 2000-04-04 Nexmed Holdings, Inc. Topical compositions for prostaglandin E1 delivery
US6118020A (en) 1999-05-19 2000-09-12 Nexmed Holdings, Inc. Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate
US6495124B1 (en) * 2000-02-14 2002-12-17 Macrochem Corporation Antifungal nail lacquer and method using same
BR0108438A (pt) * 2000-02-16 2003-04-01 Bentley Pharmaceuticals Inc Composição farmacêutica
US7074392B1 (en) 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
WO2002002503A1 (en) * 2000-07-01 2002-01-10 Chemtech Research Incorporation Process for preparation of terbinafine and its hydrochloride as an antifungal agent
JP4899139B2 (ja) * 2000-08-10 2012-03-21 株式会社ポーラファルマ 抗真菌医薬組成物
JP4803511B2 (ja) * 2000-08-25 2011-10-26 株式会社ポーラファルマ 抗真菌医薬組成物
JP2002068975A (ja) * 2000-08-25 2002-03-08 Pola Chem Ind Inc 抗真菌医薬組成物
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
US6846837B2 (en) * 2002-06-21 2005-01-25 Howard I. Maibach Topical administration of basic antifungal compositions to treat fungal infections of the nails

Also Published As

Publication number Publication date
NO20054830L (no) 2005-12-16
IS8078A (is) 2005-10-18
CO5640092A2 (es) 2006-05-31
NO335895B1 (no) 2015-03-16
SG152065A1 (en) 2009-05-29
ATE512672T1 (de) 2011-07-15
AU2004224326A1 (en) 2004-10-07
NZ542904A (en) 2009-04-30
AU2004224326B2 (en) 2010-04-22
CY1111773T1 (el) 2015-10-07
HRP20050918A2 (en) 2006-12-31
US20130323189A1 (en) 2013-12-05
RU2005132390A (ru) 2006-06-27
EP2106805B1 (en) 2011-06-15
US20060067898A1 (en) 2006-03-30
JP2006520800A (ja) 2006-09-14
DK1635770T3 (da) 2009-08-03
NO20054830D0 (no) 2005-10-19
KR20060003868A (ko) 2006-01-11
IL170963A (en) 2010-12-30
US7462362B2 (en) 2008-12-09
US20090099266A1 (en) 2009-04-16
PL2106805T3 (pl) 2011-10-31
EP1635770B1 (en) 2009-05-27
RU2358718C2 (ru) 2009-06-20
TNSN05231A1 (fr) 2007-06-11
KR101093990B1 (ko) 2011-12-16
MXPA05010114A (es) 2006-04-27
MA27760A1 (fr) 2006-02-01
ES2366273T3 (es) 2011-10-18
ZA200507972B (en) 2007-02-28
DE602004021253D1 (de) 2009-07-09
JP4540667B2 (ja) 2010-09-08
CA2519705A1 (en) 2004-10-07
EP2106805A1 (en) 2009-10-07
ATE432087T1 (de) 2009-06-15
EP1635770A2 (en) 2006-03-22
DK2106805T3 (da) 2011-08-15
BRPI0408613A (pt) 2006-03-07
CN102973420A (zh) 2013-03-20
CA2519705C (en) 2013-07-02
WO2004084826A2 (en) 2004-10-07
WO2004084826A3 (en) 2004-11-04
CN1791378A (zh) 2006-06-21
EP1635770A4 (en) 2007-12-26

Similar Documents

Publication Publication Date Title
ECSP056110A (es) Revestimiento anti-fúngico para uñas y método de uso
ATE238751T1 (de) Antimykotischer nagellack
BR0206885A (pt) Revestimentos de polìmeros de flúor coalescentes a baixas temperaturas
DE60326966D1 (de) Selbstvernetzbare wässrige beschichtungszusammensetzung
WO2003097091A3 (en) Glucan-based vaccines
DE60000103D1 (de) Eine wässrige polymerdispersion enthaltender nagellack
BR0212992A (pt) Processo para a preparação de poliisocianatos, composição dos mesmos, composição de revestimento, substrato revestido e substrato automotivo
ATE347871T1 (de) Vorgeformte folie zur topischen anwendung
CN102046009A (zh) 用于甲真菌治疗的组合物和方法
ATE556698T1 (de) Kosmetische zusammensetzung mit einem flockenden wasserlöslichen polymer als antiperspirans; verfahren zur behandlung von perspiration
BRPI0508795A (pt) composição de tratamento capilar, uso da composição, método de tratamento de cabelos e método de fabricação de composição de tratamento capilar
DE60326744D1 (de) Zahnbeschichtungsset
EP1152014A4 (en) RESIN COMPOSITION
EP1028149A3 (en) Aqueous coating and method for film formation using the same
ITBO20020599A1 (it) Vernice, procedimento di preparazione e relativo impiego su di un supporto legnoso.
ES1053857U (es) Pintauñas de un solo uso.
ATE322881T1 (de) Haarstyling zusammensetzung
WO2001010959A3 (en) Solvent based wood filler
KR200367525Y1 (ko) 비점착성 도료가 코팅된 이미용 핀셋
TH45854A3 (th) สารผสมเคลือบเล็บโพลิอะคริลและโพลิยูรีเทน
TH41747A3 (th) สารผสมเคลือบเล็บ
CY1116454T1 (el) Ενωσεις βιοκτονου βοριουχου φθαλιδιου